Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NRP1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MARCH7 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
TJP1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
RBMS3 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
PUM2 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
RICTOR - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
CSNK1A1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
LPAR6 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
GLUD1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
DLAT - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
LARP4 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
SLC16A1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
USP31 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
COX15 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
PREX2 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OPA1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
ETS1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
MMAA - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
SCYL2 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
PDE8A - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on